Portal vein involvement is considered one of the most fearful complications of hepatocellular
carcinoma (HCC). Portal vein tumor thrombosis (PVTT) is associated with aggressive tumor …

Simple Summary Transplant oncology is an emerging concept of cancer treatment with a
promising prospective outcome. The application of oncology, transplant medicine, and …

Simple Summary Transplant oncology is an evolving treatment ideal for patients suffering
from various cancers with poor prognoses. The concept essentially is the complete removal …

Simple Summary Cholangiocarcinoma is a relatively rare but deadly disease with
traditionally limited treatment options. The disease can be categorized by anatomic location …

The widespread uptake of different machine perfusion (MP) strategies for liver transplant has
been driven by an effort to minimize graft injury. Damage to the cholangiocytes during the …

Interventional therapies are increasingly used in clinical trials for hepatocellular carcinoma
(HCC). Sorafenib is the front-line remedy for HCC, however, chemoresistance occurs …

Background Cholangiocarcinoma management is constantly being updated in view of
existing evidence in order to establish practice guidelines and consensus statements …

The effectiveness of liver transplantation to cure numerous diseases, alleviate suffering, and
improve patient survival has led to an ever increasing demand. Improvements in …

Cholangiocarcinoma (CCA) is the second most common primary hepatic malignancy
following hepatocellular carcinoma (HCC). It is an aggressive malignancy with an extremely …

Cholangiocarcinoma (CCA) encompasses all malignant neoplasms arising from the
epithelial cells of the biliary tree. About 40% of CCAs are perihilar, involving the bile ducts …